Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development
Authors
Lorna Ćorak
Clinical Department for Respiratory Diseases Jordanovac, University Hospital Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia
Miroslav Samaržija
Clinical Department for Respiratory Diseases Jordanovac, University Hospital Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia
Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany
Division of Pediatric Neurooncology German Cancer Research Center (DKFZ) German Cancer Consortium (DKTK), Heidelberg, Germany
Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia
Faculty of Dental Medicine and Health, University of Osijek, Osijek, Croatia
Language: English
Page range: 243 - 256
Accepted on: Jan 9, 2023
Published on: Jun 12, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2023 Jurica Baranasic, Yasmeen Niazi, Subhayan Chattopadhyay, Lada Rumora, Lorna Ćorak, Andrea Vukić Dugac, Marko Jakopović, Miroslav Samaržija, Asta Försti, Jelena Knežević, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.